PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway

Abstract Oral cavity squamous cell carcinoma (OSCC) represents the most prevalent malignancy among head and neck squamous cell carcinomas (HNSCCs). Standard treatment modalities include surgical resection combined with radiation and chemotherapy. However, locoregional failure remains a critical issu...

Full description

Saved in:
Bibliographic Details
Main Authors: Chun-I Wang, Cheng-Yi Chen, Ting-Wen Chen, Chun-Chia Cheng, Shu-Wen Hong, Tsung-You Tsai, Kai-Ping Chang
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02286-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545005845446656
author Chun-I Wang
Cheng-Yi Chen
Ting-Wen Chen
Chun-Chia Cheng
Shu-Wen Hong
Tsung-You Tsai
Kai-Ping Chang
author_facet Chun-I Wang
Cheng-Yi Chen
Ting-Wen Chen
Chun-Chia Cheng
Shu-Wen Hong
Tsung-You Tsai
Kai-Ping Chang
author_sort Chun-I Wang
collection DOAJ
description Abstract Oral cavity squamous cell carcinoma (OSCC) represents the most prevalent malignancy among head and neck squamous cell carcinomas (HNSCCs). Standard treatment modalities include surgical resection combined with radiation and chemotherapy. However, locoregional failure remains a critical issue affecting the prognosis of OSCC patients, largely due to tumor resistance against radiation or chemotherapy. In this study, we established a gene database related to OSCC recurrence and identified PSMA2 as a novel molecule influencing prognosis in OSCC patients. An independent Taiwanese cohort confirmed that elevated PSMA2 transcript levels were associated with poorer prognosis and contributed to the chemo- and radioresistance phenotype in OSCC. Furthermore, we confirmed that PSMA2 regulates cell cycle, mitochondrial dysfunction, and mitophagy, thereby contributing to carcinogenesis and resistance. Notably, mitophagy inducer exhibit antitumor effects in PSMA2-overexpressing OSCC xenograft mouse model. Collectively, our results provide a mechanistic understanding of the atypical function of PSMA2 in promoting OSCC recurrence.
format Article
id doaj-art-d07c682a14024963bd84c64a017cd802
institution Kabale University
issn 2058-7716
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-d07c682a14024963bd84c64a017cd8022025-01-12T12:08:17ZengNature Publishing GroupCell Death Discovery2058-77162025-01-0111111210.1038/s41420-025-02286-2PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathwayChun-I Wang0Cheng-Yi Chen1Ting-Wen Chen2Chun-Chia Cheng3Shu-Wen Hong4Tsung-You Tsai5Kai-Ping Chang6Department of Biochemistry, School of Medicine, China Medical UniversityDepartment of Cell Biology and Anatomy, College of Medicine, National Cheng Kung UniversityInstitute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung UniversityRadiation Biology Research Center, Institute for Radiological Research, Chang Gung University/ Linkou Chang Gung Memorial HospitalDepartment of Biochemistry, School of Medicine, China Medical UniversityDepartment of Otolaryngology-Head & Neck Surgery, Linkou Chang Gung Memorial HospitalDepartment of Otolaryngology-Head & Neck Surgery, Linkou Chang Gung Memorial HospitalAbstract Oral cavity squamous cell carcinoma (OSCC) represents the most prevalent malignancy among head and neck squamous cell carcinomas (HNSCCs). Standard treatment modalities include surgical resection combined with radiation and chemotherapy. However, locoregional failure remains a critical issue affecting the prognosis of OSCC patients, largely due to tumor resistance against radiation or chemotherapy. In this study, we established a gene database related to OSCC recurrence and identified PSMA2 as a novel molecule influencing prognosis in OSCC patients. An independent Taiwanese cohort confirmed that elevated PSMA2 transcript levels were associated with poorer prognosis and contributed to the chemo- and radioresistance phenotype in OSCC. Furthermore, we confirmed that PSMA2 regulates cell cycle, mitochondrial dysfunction, and mitophagy, thereby contributing to carcinogenesis and resistance. Notably, mitophagy inducer exhibit antitumor effects in PSMA2-overexpressing OSCC xenograft mouse model. Collectively, our results provide a mechanistic understanding of the atypical function of PSMA2 in promoting OSCC recurrence.https://doi.org/10.1038/s41420-025-02286-2
spellingShingle Chun-I Wang
Cheng-Yi Chen
Ting-Wen Chen
Chun-Chia Cheng
Shu-Wen Hong
Tsung-You Tsai
Kai-Ping Chang
PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
Cell Death Discovery
title PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
title_full PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
title_fullStr PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
title_full_unstemmed PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
title_short PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
title_sort psma2 promotes chemo and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway
url https://doi.org/10.1038/s41420-025-02286-2
work_keys_str_mv AT chuniwang psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway
AT chengyichen psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway
AT tingwenchen psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway
AT chunchiacheng psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway
AT shuwenhong psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway
AT tsungyoutsai psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway
AT kaipingchang psma2promoteschemoandradioresistanceoforalsquamouscellcarcinomabymodulatingmitophagypathway